Brought to you by 
PeptiDream uses PDPS tech to discover new drug projects for Sanofi
01 Feb 2023
Executive Summary
PeptiDream Inc. agreed to use its Peptide Discovery Platform System (PDPS) macrocyclic/constrained peptide generation platform against multiple undisclosed targets selected by Sanofi.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Technologies
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PeptiDream uses PDPS tech to discover new drug projects for Sanofi
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice